Results 301 to 310 of about 7,716,482 (438)

Assessment of patient preferences for assisted reproductive technology in China: a discrete choice experiment. [PDF]

BMJ Open
Chen J, Bao Y, Liu Y, Sun Y, Qian X, Fang K, Wan B, Ding H, Zhang L, Li X.   +9 more
europepmc   +1 more source

Screening standards in assisted reproductive technologies [PDF]

, 2001
Corinne Liesnard, Elodie Strebelle, Yvon Englert   +2 more
openalex   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

Comprehensive meta-analysis reveals association between multiple imprinting disorders and conception by assisted reproductive technology

Journal of Assisted Reproduction and Genetics, 2018
V. Cortessis, M. Azadian, J. Buxbaum, Fatimata Sanogo, Ashley Song, I. Sriprasert, P. Wei, Jing Yu, K. Chung, K. Siegmund   +9 more
semanticscholar   +1 more source

Environmental pollution and human fertility: investigating the relationship between PM2.5 exposure and assisted reproductive technology outcomes. [PDF]

BMC Public Health
Li F, Duan X, Li M, Gao Y, Kang Y, Zheng W, Guo X, Chen Y.   +7 more
europepmc   +1 more source

Reproductive Technology and Rights [PDF]

Journal of Medical Ethics, 1997
openaire   +2 more sources

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Effect of aging on semen and embryonic developmental scores in assisted reproductive technology. [PDF]

Reprod Med Biol
Yamamoto T, Mine K, Iwata H.
europepmc   +1 more source

Rights, technology, and services in reproductive health. A report from a meeting, 6-7 May 1999

, 2000
Marion Carter, Charlie McGrory
openalex   +2 more sources

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source